While certain HCCs show low or absent ASS expression, and must rely on exogenous arginine for survival [16], in our clinical trial, we have found that tumor cells can undergo autophagy and subsequently turn on the ASS gene, resulting in drug resistance. Here, ASS1 is linked to neoplasm.